Patents by Inventor Elaine M. Liversidge

Elaine M. Liversidge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS
    Publication number: 20150238505
    Abstract: Described are injectable formulations of particulate olanzapine that produce a prolonged duration of action upon administration, and methods of making and using such formulations. The injectable formulations comprise particulate olanzapine.
    Type: Application
    Filed: February 27, 2015
    Publication date: August 27, 2015
    Inventors: Stephen B. Ruddy, David Czekai, Gary Liversidge, Scott A. Jenkins, Elaine M. Liversidge
  • Injectable Nanoparticulate Olanzapine Formulations
    Publication number: 20130309310
    Abstract: Described are injectable formulations of particulate olanzapine that produce a prolonged duration of action upon administration, and methods of making and using such formulations. The injectable formulations comprise particulate olanzapine.
    Type: Application
    Filed: July 24, 2013
    Publication date: November 21, 2013
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Stephen B. Ruddy, David Czekai, Gary Liversidge, Scott A. Jenkins, Elaine M. Liversidge
  • INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS
    Publication number: 20120315336
    Abstract: Described are injectable formulations of particulate olanzapine that produce a prolonged duration of action upon administration, and methods of making and using such formulations. The injectable formulations comprise particulate olanzapine.
    Type: Application
    Filed: May 3, 2012
    Publication date: December 13, 2012
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Stephen B. Ruddy, David Czekai, Gary Liversidge, Scott A. Jenkins, Elaine M. Liversidge
  • INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS
    Publication number: 20090155331
    Abstract: Described are injectable formulations of particulate olanzapine that produce a prolonged duration of action upon administration, and methods of making and using such formulations. The injectable formulations comprise particulate olanzapine.
    Type: Application
    Filed: December 11, 2008
    Publication date: June 18, 2009
    Applicant: Elan Pharma International Limited
    Inventors: Stephen B. Ruddy, David Czekai, Gary Liversidge, Scott A. Jenkins, Elaine M. Liversidge
  • Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
    Patent number: 5834025
    Abstract: Disclosed are methods of intravenous administration of nanoparticulate drug formulations to a mammal to avoid adverse hemodynamic effects: by reducing the rate and concentration of the nanoparticles in the formulations; or by pre-treating the subject with histamine; or by pretreating the subject with a desensitizing amount of the nanoparticulate drug formulations.
    Type: Grant
    Filed: August 14, 1996
    Date of Patent: November 10, 1998
    Assignee: Nanosystems L.L.C.
    Inventors: Lawrence de Garavilla, Elaine M. Liversidge, Gary G. Liversidge
  • Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
    Patent number: 5569448
    Abstract: This invention provides a composition comprised of nanoparticles containing a therapeutic or diagnostic agent having a block copolymer linked to at least one anionic group as a surface modifier adsorbed on the surface thereof and a method of making such nanoparticles. The compositions exhibit unexpectedly improved autoclave stability, reduced macrophage uptake, improved toxicological profiles and facilitate particle size reduction such that milling time can be reduced and/or sterile filtration of the nanoparticles can be accomplished.
    Type: Grant
    Filed: January 24, 1995
    Date of Patent: October 29, 1996
    Assignee: Nano Systems L.L.C.
    Inventors: Sui-Ming Wong, Ian M. Newington, Elaine M. Liversidge, Gregory L. McIntire, Alan R. Pitt, Jack M. Shaw